Canada Exclusive-Canada's Ontario to expand use of AstraZeneca COVID vaccine as epidemic rages
Blood clot risks: Comparing COVID-19 vaccines with common medicines, travel and smoking
The likelihood of getting blood clots from pregnancy, birth control pills and COVID-19 itself is higher than from the vaccines, experts say.On Tuesday, Canada reported its first case of a rare blood clot in a person who had received the AstraZeneca COVID-19 vaccine.
By Allison Martell
TORONTO (Reuters) - The Canadian province of Ontario will begin offering AstraZeneca's COVID-19 vaccine on Tuesday to people turning 40 or older this year, according to a government source.
The change will broaden access to vaccines as a third wave of infections threatens to overwhelm hospitals in Canada's most-populous province, and should make it easier to use doses that in some cases have been accumulating at pharmacies.
The change will be announced on Monday and go into effect across the province on Tuesday, according to the source. The vaccine has already been distributed to pharmacies but currently can only be given to people turning 55 or older this year.
Mickey Guyton Is Once Again Making History at the ACM Awards
Mickey Guyton is making history once again!
Ontario announced new public health measures on Friday, promising checkpoints at provincial borders, new police powers and closing outdoor amenities, while leaving many workplaces open. The measures were widely criticized by doctors and public health experts, and the province quickly reopened playgrounds and modified the new police powers.
On March 29, Health Canada said it would review reports of serious blood clots and bleeding in a small number of people who had received the AstraZeneca vaccine in other countries, and an independent panel called the National Advisory Council on Immunization (NACI) recommended that it only be given to people 55 and older. All provinces followed that advice.
But NACI's recommendations are not binding. Last week, Health Canada, the country's drug regulator, said it had reviewed all available evidence and would not restrict the use of the vaccine, because its benefits outweigh its potential risks. Health Canada said at the time that NACI was reviewing its recommendations.
COVID-19 Update: Alberta to lower eligibility age for AstraZeneca | Many students shift online today | Cancer patients call for second dose
With news on COVID-19 happening rapidly, we’ve created this page to bring you our latest stories and information on the outbreak in and around Calgary. What’s happening now Thousands of students in Calgary and in northern Alberta are shifting to online learning today because of rising COVID-19 infection rates. Following Ontario’s lead, Alberta will also expand use of the AstraZeneca vaccine to people aged 40 and over. Ontario will expand use of the AstraZeneca vaccine to people 40 and older, starting Tuesday. Calgary daycares and preschools are seeing more COVID-19 outbreaks. Alberta reported 1,516 new cases of COVID-19 on Sunday, as well as three additional deaths.
On Sunday, NACI's chair told Reuters that the panel would make a new recommendation on Tuesday.
Health Canada said regulators in the UK had estimated the risk of clots to be very small, roughly four in a million people who receive the vaccine. It also said the complication was treatable. Two people have developed it in Canada, and both are recovering.
Several other countries have limited the use of the vaccine to older people. Denmark has withdrawn the shot, and Norway said on Thursday it would take more time to decide whether to resume use.
Ontario reported 4,250 new cases of COVID-19 on Sunday. The Ontario Hospital Association said 59 patients were admitted to intensive care on Saturday, bringing the number of COVID-19 patients in ICUs to 737.
Health Canada says those who receive the vaccine should seek medical attention immediately if they experience shortness of breath, chest pain, leg swelling, persistent belly pain, neurological symptoms like severe headaches or blurred vision, or skin bruising or tiny blood spots under the skin beyond the site of the injection.
(Reporting by Allison Martell; Editing by Diane Craft and Peter Cooney)
COVID-19: Ontario reports first AZ-related case of rare blood clotting; Tam sees signs of easing .
Province reports 4,505 new cases and 34 COVID-19 related deaths Ottawa sees 254 new cases, no new deaths Canada signs deal for millions of vaccine boosters through 2023 Ontario has recorded its first case of rare blood clotting involving a male patient in his 60s who had recently received his first dose of the AstraZeneca vaccine. “We have confirmed the first case of the rare blood clotting condition known as vaccine-induced immune thrombotic thrombocytopenia (VITT) in Ontario,” said chief medical officer of health Dr. David Williams in a statement Friday morning.